MediWound Ltd. – NASDAQ:MDWD
Founder-led company
MediWound Ltd. stock price today
$17.35
-0.34
-1.98%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 11 hours
MediWound Ltd. stock price monthly change
-16.35%
month
MediWound Ltd. stock price quarterly change
-16.35%
quarter
MediWound Ltd. stock price yearly change
+72.01%
year
MediWound Ltd. key metrics
Market Cap | 178.02M |
Enterprise value | N/A |
P/E | -3.59 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | 146.85 |
Price/Book | 1805.92 |
PEG ratio | 0.07 |
EPS | -1.38 |
Revenue | 19.85M |
EBITDA | -13.27M |
Income | -12.75M |
Revenue Q/Q | 30.66% |
Revenue Y/Y | -23.31% |
Profit margin | -80.05% |
Oper. margin | -67.17% |
Gross margin | 32.14% |
EBIT margin | -67.17% |
EBITDA margin | -66.89% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeMediWound Ltd. stock price history
MediWound Ltd. stock forecast
MediWound Ltd. financial statements
Average Price Target
$28
Potential upside: 61.38%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 4.77M | 916K | 19.19% |
|---|---|---|---|
| Sep 2023 | 4.77M | -2.19M | -45.98% |
| Dec 2023 | 5.33M | -1.74M | -32.65% |
| Mar 2024 | 4.96M | -9.72M | -195.99% |
| Jun 2023 | 64366000 | 29.43M | 45.73% |
|---|---|---|---|
| Sep 2023 | 67017000 | 33.96M | 50.68% |
| Dec 2023 | 66459000 | 27.18M | 40.91% |
| Mar 2024 | 62377000 | 31.39M | 50.34% |
| Jun 2023 | -5.25M | -26.07M | -405K |
|---|---|---|---|
| Sep 2023 | -3.25M | -5.82M | -727K |
| Dec 2023 | -1.80M | 4.76M | -204K |
| Mar 2024 | -4.00M | -2.38M | -699K |
MediWound Ltd. alternative data
| Aug 2023 | 83 |
|---|---|
| Sep 2023 | 83 |
| Oct 2023 | 83 |
| Nov 2023 | 83 |
| Dec 2023 | 83 |
| Jan 2024 | 83 |
| Feb 2024 | 83 |
| Mar 2024 | 100 |
| Apr 2024 | 100 |
| May 2024 | 100 |
| Jun 2024 | 100 |
| Jul 2024 | 100 |
MediWound Ltd. other data
| Quarter | Transcript |
|---|---|
| Q1 2024 29 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 21 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 21 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 16 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Mr. Sharon Malka CPA, MBA (1972) Chief Executive Officer | $520,000 |
Prof. Lior Rosenberg M.D. (1946) Co-Founder & Chief Medical Technology Officer | $440,000 |
Dr. Ety Klinger (1962) Chief R&D Officer | $375,000 |
Mr. Boaz Gur-Lavie CPA, M.B.A. (1974) Chief Financial Officer | $341,000 |
Mr. Yaron Meyer (1979) Executive Vice President, Gen. Counsel & Corporation Sec. | $315,000 |
-
What's the price of MediWound Ltd. stock today?
One share of MediWound Ltd. stock can currently be purchased for approximately $17.35.
-
When is MediWound Ltd.'s next earnings date?
Unfortunately, MediWound Ltd.'s (MDWD) next earnings date is currently unknown.
-
Does MediWound Ltd. pay dividends?
No, MediWound Ltd. does not pay dividends.
-
How much money does MediWound Ltd. make?
MediWound Ltd. has a market capitalization of 178.02M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 29.48% to 18.69M US dollars.
-
What is MediWound Ltd.'s stock symbol?
MediWound Ltd. is traded on the NASDAQ under the ticker symbol "MDWD".
-
What is MediWound Ltd.'s primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of MediWound Ltd.?
Shares of MediWound Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are MediWound Ltd.'s key executives?
MediWound Ltd.'s management team includes the following people:
- Mr. Sharon Malka CPA, MBA Chief Executive Officer(age: 53, pay: $520,000)
- Prof. Lior Rosenberg M.D. Co-Founder & Chief Medical Technology Officer(age: 79, pay: $440,000)
- Dr. Ety Klinger Chief R&D Officer(age: 63, pay: $375,000)
- Mr. Boaz Gur-Lavie CPA, M.B.A. Chief Financial Officer(age: 51, pay: $341,000)
- Mr. Yaron Meyer Executive Vice President, Gen. Counsel & Corporation Sec.(age: 46, pay: $315,000)
-
Is MediWound Ltd. founder-led company?
Yes, MediWound Ltd. is a company led by its founder Prof. Lior Rosenberg M.D..
-
How many employees does MediWound Ltd. have?
As Jul 2024, MediWound Ltd. employs 100 workers.
-
When MediWound Ltd. went public?
MediWound Ltd. is publicly traded company for more then 11 years since IPO on 20 Mar 2014.
-
What is MediWound Ltd.'s official website?
The official website for MediWound Ltd. is mediwound.com.
-
How can i contact MediWound Ltd.?
MediWound Ltd. can be reached via phone at +972 77 971 4100.
-
What is MediWound Ltd. stock forecast & price target?
Based on 1 Wall Street analysts` predicted price targets for MediWound Ltd. in the last 12 months, the avarage price target is $28. The average price target represents a 61.38% change from the last price of $17.35.
MediWound Ltd. company profile:
MediWound Ltd.
mediwound.comExchange:
NASDAQ
Full time employees:
100
Industry:
Biotechnology
Sector:
Healthcare
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.
42 Hayarkon Street
Yavne, 8122745
Yavne, 8122745
CIK: 0001593984
ISIN: IL0011316309
CUSIP: M68830104
